Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.
暂无分享，去创建一个
T. Choueiri | N. Agarwal | A. Alva | I. Davis | A. Kapoor | C. Kollmannsberger | B. Beuselinck | P. Ravi | W. Xie | D. Heng | F. Donskov | L. Wood | F. Parnis | Z. Bakouny | J. Steinharter | C. Gan | J. Shapiro | J. M. Morales | Shaan Dudani | C. Wells